Transcriptional regulation of oncogenic protein kinase Cε (PKCε) by STAT1 and Sp1 proteins

Journal of Biological Chemistry

Volumn 289, Issue 28, 2014, Pages 19823-19838

  Wang, HongBin ^a   Gutierrez Uzquiza, Alvaro ^a   Garg, Rachana ^a   Barrio Real, Laura ^a   Abera, Mahlet B ^a   Lopez Haber, Cynthia ^a   Rosemblit, Cinthia ^a   Lu, Huaisheng ^a   Abba, Martin ^b   Kazanietz, Marcelo G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CLONING; DISEASES; ENZYMES; GENE EXPRESSION; PROTEINS;

CANCER THERAPEUTICS; DELETIONAL ANALYSIS; MALIGNANT TRANSFORMATIONS; MAMMARY EPITHELIAL CELLS; PROMOTER ACTIVITIES; PROTEIN EXPRESSIONS; TRANSCRIPTIONAL ACTIVITY; TRANSCRIPTIONAL REGULATION;

GENE EXPRESSION REGULATION;

MESSENGER RNA; PROTEIN KINASE C EPSILON; SERINE; STAT1 PROTEIN; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE SILENCING; HUMAN; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN KINASE C EPSILON GENE; PROTEIN LOCALIZATION; PROTEIN METHYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RNA INTERFERENCE; RNA SEQUENCE; TRANSCRIPTION REGULATION; UPREGULATION;

BREAST CANCER; DIACYLGLYCEROL; GENE EXPRESSION; PROTEIN KINASE; PROTEIN KINASE C (PKCΕ); SIGNAL TRANSDUCTION; SPECIFICITY PROTEIN 1 (SP1); STAT TRANSCRIPTION FACTOR; TRANSCRIPTION PROMOTER;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; PROTEIN KINASE C-EPSILON; RESPONSE ELEMENTS; RNA, MESSENGER; RNA, NEOPLASM; SP1 TRANSCRIPTION FACTOR; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84904157292     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.548446     Document Type: Article

References (73)

1. Kampfer, S., Windegger, M., Hochholdinger, F., Schwaiger, W., Pestell, R. G., Baier, G., Grunicke, H. H., and Uberall, F. (2001) Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras. J. Biol. Chem. 276, 42834-42842
2. Mesquita, R. F., Paul, M. A., Valmaseda, A., Francois, A., Jabr, R., Anjum, S., Marber, M. S., Budhram-Mahadeo, V., and Heads, R. J. (2014) Protein kinase Cε-calcineurin cosignaling downstream of toll-like receptor 4 downregulates fibrosis and induces wound healing gene expression in cardiac myofibroblasts. Mol. Cell Biol. 34, 574-594
3. Quann, E. J., Liu, X., Altan-Bonnet, G., and Huse, M. (2011) A cascade of protein kinase C isozymes promotes cytoskeletal polarization in T cells. Nat. Immunol. 12, 647-654
4. Saurin, A. T., Durgan, J., Cameron, A. J., Faisal, A., Marber, M. S., and Parker, P. J. (2008) The regulated assembly of a PKCε complex controls the completion of cytokinesis. Nat. Cell Biol. 10, 891-901
5. Soh, J. W., and Weinstein, I. B. (2003) Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J. Biol. Chem. 278, 34709-34716
6. Wu, D. F., Chandra, D., McMahon, T., Wang, D., Dadgar, J., Kharazia, V. N., Liang, Y. J., Waxman, S. G., Dib-Hajj, S. D., and Messing, R. O. (2012) PKCε phosphorylation of the sodium channel NaV1.8 increases channel function and produces mechanical hyperalgesia in mice. J. Clin. Invest. 122, 1306-1315
7. Churchill, E. N., Ferreira, J. C., Brum, P. C., Szweda, L. I., and Mochly-Rosen, D. (2010) Ischaemic preconditioning improves proteasomal activity and increases the degradation of δPKC during reperfusion. Cardiovasc. Res. 85, 385-394
8. Jornayvaz, F. R., and Shulman, G. I. (2012) Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. Cell Metab. 15, 574-584
9. Lee, A. M., and Messing, R. O. (2011) Protein kinase C ε modulates nicotine consumption and dopamine reward signals in the nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A. 108, 16080-16085
10. Zhang, D., Christianson, J., Liu, Z. X., Tian, L., Choi, C. S., Neschen, S., Dong, J., Wood, P. A., and Shulman, G. I. (2010) Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency. Cell Metab. 11, 402-411
11. Cacace, A. M., Guadagno, S. N., Krauss, R. S., Fabbro, D., and Weinstein, I. B. (1993) The ε isoform of protein kinase C is an oncogene when over-expressed in rat fibroblasts. Oncogene 8, 2095-2104 (Pubitemid 23226942)
12. Su, T., Straight, S., Bao, L., Xie, X., Lehner, C. L., Cavey, G. S., Teknos, T. N., and Pan, Q. (2013) PKCε phosphorylates and mediates the cell membrane localization of RhoA. ISRN Oncol. 2013, 329063
13. Griner, E. M., and Kazanietz, M. G. (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer 7, 281-294 (Pubitemid 46480971)
14. Garg, R., Benedetti, L. G., Abera, M. B., Wang, H., Abba, M., and Kazanietz, M. G. (2013) Protein kinase C and cancer: what we know and what we do not. Oncogene 10.1038/onc.2013.524
15. Mischak, H., Goodnight, J. A., Kolch, W., Martiny-Baron, G., Schaechtle, C., Kazanietz, M. G., Blumberg, P. M., Pierce, J. H., and Mushinski, J. F. (1993) Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J. Biol. Chem. 268, 6090-6096 (Pubitemid 23099293)
16. Perletti, G. P., Folini, M., Lin, H. C., Mischak, H., Piccinini, F., and Tashjian, A. H., Jr. (1996) Overexpression of protein kinase C ε is oncogenic in rat colonic epithelial cells. Oncogene 12, 847-854 (Pubitemid 26072270)
17. Benavides, F., Blando, J., Perez, C. J., Garg, R., Conti, C. J., DiGiovanni, J., and Kazanietz, M. G. (2011) Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions. Cell Cycle 10, 268-277
18. Garg, R., Blando, J., Perez, C. J., Wang, H., Benavides, F. J., and Kazanietz, M. G. (2012) Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase Cε (PKCε). J. Biol. Chem. 287, 37570-37582
19. Ding, L., Wang, H., Lang, W., and Xiao, L. (2002) Protein kinase C-ε promotes survival of lung cancer cells by suppressing apoptosis through dysregulation of the mitochondrial caspase pathway. J. Biol. Chem. 277, 35305-35313
20. Körner, C., Keklikoglou, I., Bender, C., Wörner, A., Münstermann, E., and Wiemann, S. (2013) MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase Cε (PKCε). J. Biol. Chem. 288, 8750-8761
21. Shankar, E., Sivaprasad, U., and Basu, A. (2008) Protein kinase Cε confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53. Oncogene 27, 3957-3966 (Pubitemid 351913642)
22. Pan, Q., Bao, L. W., Kleer, C. G., Sabel, M. S., Griffith, K. A., Teknos, T. N., and Merajver, S. D. (2005) Protein kinase Cε is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. Cancer Res. 65, 8366-8371 (Pubitemid 41330602)
23. Wu, D., Foreman, T. L., Gregory, C. W., McJilton, M. A., Wescott, G. G., Ford, O. H., Alvey, R. F., Mohler, J. L., and Terrian, D. M. (2002) Protein kinase Cε has the potential to advance the recurrence of human prostate cancer. Cancer Res. 62, 2423-2429 (Pubitemid 34411727)
24. Aziz, M. H., Manoharan, H. T., Church, D. R., Dreckschmidt, N. E., Zhong, W., Oberley, T. D., Wilding, G., and Verma, A. K. (2007) Protein kinase Cε interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. Cancer Res. 67, 8828-8838 (Pubitemid 47437459)
25. Caino, M. C., Lopez-Haber, C., Kissil, J. L., and Kazanietz, M. G. (2012) Non-small cell lung carcinoma cell motility, rac activation and metastatic dissemination are mediated by protein kinase Cε. PLoS One 7, e31714
26. Dann, S. G., Golas, J., Miranda, M., Shi, C., Wu, J., Jin, G., Rosfjord, E., Upeslacis, E., and Klippel, A. (2013) p120 catenin is a key effector of a Ras-PKCvarε oncogenic signaling axis. Oncogene
27. Caino, M. C., Lopez-Haber, C., Kim, J., Mochly-Rosen, D., and Kazanietz, M. G. (2012) Proteins kinase Cvarε is required for non-small cell lung carcinoma growth and regulates the expression of apoptotic genes. Oncogene 31, 2593-2600
28. Wang, H., Xiao, L., and Kazanietz, M. G. (2011) p23/Tmp21 associates with protein kinase Cδ (PKCδ) and modulates its apoptotic function. J. Biol. Chem. 286, 15821-15831
29. Taminau, J., Meganck, S., Lazar, C., Steenhoff, D., Coletta, A., Molter, C., Duque, R., de Schaetzen, V., Weiss Solís, D. Y., Bersini, H., and Nowé, A. (2012) Unlocking the potential of publicly available microarray data using inSilicoDb and inSilicoMerging R/Bioconductor packages. BMC Bioinformatics 13, 335
30. Gutiérrez-Uzquiza, A., Árechederra, M., Bragado, P., Aguirre-Ghiso, J. A., and Porras, A. (2012) p38α mediates cell survival in response to oxidative stress via induction of antioxidant genes: effect on the p70S6K pathway. J. Biol. Chem. 287, 2632-2642
31. Lopez-Haber, C., and Kazanietz, M. G. (2013) Cucurbitacin I inhibits Rac1 activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of Janus tyrosine kinase 2 and P-Rex1. Mol. Pharmacol. 83, 1141-1154
32. Bae, K. M., Wang, H., Jiang, G., Chen, M. G., Lu, L., and Xiao, L. (2007) Protein kinase Cε is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner. Cancer Res. 67, 6053-6063 (Pubitemid 47037484)
33. Martínez-Gimeno, C., Díaz-Meco, M. T., Domínguez, I., and Moscat, J. (1995) Alterations in levels of different protein kinase C isotypes and their influence on behavior of squamous cell carcinoma of the oral cavity: εPKC, a novel prognostic factor for relapse and survival. Head Neck 17, 516-525
34. Albertini, V., Jain, A., Vignati, S., Napoli, S., Rinaldi, A., Kwee, I., Nur-e-Alam, M., Bergant, J., Bertoni, F., Carbone, G. M., Rohr, J., and Catapano, C. V. (2006) Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy. Nucleic Acids Res. 34, 1721-1734
35. Sastry, M., and Patel, D. J. (1993) Solution structure of the mithramycin dimer-DNA complex. Biochemistry 32, 6588-6604 (Pubitemid 23217128)
36. Cheng, M. B., Zhang, Y., Zhong, X., Sutter, B., Cao, C. Y., Chen, X. S., Cheng, X. K., Xiao, L., and Shen, Y. F. (2010) Stat1 mediates an autoregulation of hsp90beta gene in heat shock response. Cell Signal 22, 1206-1213
37. Ivaska, J., Bosca, L., and Parker, P. J. (2003) PKCε is a permissive link in integrin-dependent IFN-γ signalling that facilitates JAK phosphorylation of STAT1. Nat. Cell Biol. 5, 363-369 (Pubitemid 36432303)
38. Xuan, Y. T., Guo, Y., Zhu, Y., Wang, O. L., Rokosh, G., Messing, R. O., and Bolli, R. (2005) Role of the protein kinase C-ε-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation 112, 1971-1978 (Pubitemid 41377416)
39. Ramana, C. V., Chatterjee-Kishore, M., Nguyen, H., and Stark, G. R. (2000) Complex roles of Stat1 in regulating gene expression. Oncogene 19, 2619-2627 (Pubitemid 30339218)
40. Verma, A. K., Wheeler, D. L., Aziz, M. H., and Manoharan, H. (2006) Protein kinase Cε and development of squamous cell carcinoma, the non-melanoma human skin cancer. Mol. Carcinog. 45, 381-388 (Pubitemid 43865844)
41. Wang, X. B., Peng, W. Q., Yi, Z. J., Zhu, S. L., and Gan, Q. H. (2007) Expression and prognostic value of transcriptional factor Sp1 in breast cancer. Ai Zheng 26, 996-1000
42. Zannetti, A., Del Vecchio, S., Carriero, M. V., Fonti, R., Franco, P., Botti, G., D'Aiuto, G., Stoppelli, M. P., and Salvatore, M. (2000) Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res. 60, 1546-1551 (Pubitemid 30183423)
43. Mertens-Talcott, S. U., Chintharlapalli, S., Li, X., and Safe, S. (2007) The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res. 67, 11001-11011 (Pubitemid 350145930)
44. Abdelrahim, M., Samudio, I., Smith, R., 3rd, Burghardt, R., and Safe, S. (2002) Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. J. Biol. Chem. 277, 28815-28822
45. Chen, Y., and Gill, G. N. (1994) Positive and negative regulatory elements in the human erbB-2 gene promoter. Oncogene 9, 2269-2276 (Pubitemid 24228677)
46. Salvatori, L., Ravenna, L., Caporuscio, F., Principessa, L., Coroniti, G., Frati, L., Russo, M. A., and Petrangeli, E. (2011) Action of retinoic acid receptor on EGFR gene transactivation and breast cancer cell proliferation: Interplay with the estrogen receptor. Biomed. Pharmacother. 65, 307-312
47. Glait, C., Tencer, L., Ravid, D., Sarfstein, R., Liscovitch, M., and Werner, H. (2006) Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways. Exp. Cell Res. 312, 3899-3908 (Pubitemid 44633889)
48. Maor, S., Mayer, D., Yarden, R. I., Lee, A. V., Sarfstein, R., Werner, H., and Papa, M. Z. (2006) Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. J. Endocrinol. 191, 605-612 (Pubitemid 46210286)
49. Finkenzeller, G., Weindel, K., Zimmermann, W., Westin, G., and Marmé, D. (2004) Activated Neu/ErbB-2 induces expression of the vascular endothelial growth factor gene by functional activation of the transcription factor Sp 1. Angiogenesis 7, 59-68 (Pubitemid 39127772)
50. Loureiro, R. M., and D'Amore, P. A. (2005) Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine Growth Factor Rev. 16, 77-89 (Pubitemid 40279118)
51. Lee, R. J., Albanese, C., Fu, M., D'Amico, M., Lin, B., Watanabe, G., Haines, G. K., 3rd, Siegel, P. M., Hung, M. C., Yarden, Y., Horowitz, J. M., Muller, W. J., and Pestell, R. G. (2000) Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol. Cell Biol. 20, 672-683 (Pubitemid 30023109)
52. Cao, Y. X., Jean, J. C., and Williams, M. C. (2000) Cytosine methylation of an Sp1 site contributes to organ-specific and cell-specific regulation of expression of the lung epithelial gene t1α. Biochem. J. 350 Pt 3, 883-890
53. Dong, L., Jin, L., Tseng, H. Y., Wang, C. Y., Wilmott, J. S., Yosufi, B., Yan, X. G., Jiang, C. C., Scolyer, R. A., Zhang, X. D., and Guo, S. T. (2013) Oncogenic suppression of PHLPP1 in human melanoma. Oncogene 10.1038/onc.2013.420
54. Kitazawa, S., Kitazawa, R., and Maeda, S. (1999) Transcriptional regulation of rat cyclin D1 gene by CpG methylation status in promoter region. J. Biol. Chem. 274, 28787-28793
55. Patterson, A. J., Xiao, D., Xiong, F., Dixon, B., and Zhang, L. (2012) Hypoxia-derived oxidative stress mediates epigenetic repression of PKCε gene in foetal rat hearts. Cardiovasc. Res. 93, 302-310
56. Xiong, F., Xiao, D., and Zhang, L. (2012) Norepinephrine causes epigenetic repression of PKCε gene in rodent hearts by activating Nox1-dependent reactive oxygen species production. FASEB J. 26, 2753-2763
57. Hagiwara, K., Ito, H., Murate, T., Miyata, Y., Ohashi, H., and Nagai, H. (2012) PROX1 overexpression inhibits protein kinase CßII transcription through promoter DNA methylation. Genes Chromosomes Cancer 51, 1024-1036
58. Jin, H., Kanthasamy, A., Anantharam, V., Rana, A., and Kanthasamy, A. G. (2011) Transcriptional regulation of pro-apoptotic protein kinase Cδ: implications for oxidative stress-induced neuronal cell death. J. Biol. Chem. 286, 19840-19859
59. Andl, C. D., Mizushima, T., Oyama, K., Bowser, M., Nakagawa, H., and Rustgi, A. K. (2004) EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G1227-G1237 (Pubitemid 39551854)
60. Chan, S. R., Vermi, W., Luo, J., Lucini, L., Rickert, C., Fowler, A. M., Lonardi, S., Arthur, C., Young, L. J., Levy, D. E., Welch, M. J., Cardiff, R. D., and Schreiber, R. D. (2012) STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas. Breast Cancer Res. 14, R16
61. Hix, L. M., Karavitis, J., Khan, M. W., Shi, Y. H., Khazaie, K., and Zhang, M. (2013) Tumor STAT1 transcription factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived suppressor cells. J. Biol. Chem. 288, 11676-11688
62. Magkou, C., Giannopoulou, I., Theohari, I., Fytou, A., Rafailidis, P., Nomikos, A., Papadimitriou, C., and Nakopoulou, L. (2012) Prognostic significance of phosphorylated STAT-1 expression in premenopausal and postmenopausal patients with invasive breast cancer. Histopathology 60, 1125-1132
63. Greenwood, C., Metodieva, G., Al-Janabi, K., Lausen, B., Alldridge, L., Leng, L., Bucala, R., Fernandez, N., and Metodiev, M. V. (2012) Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and lymph node metastasis in triple-negative breast cancer. J. Proteomics 75, 3031-3040
64. Rajski, M., Vogel, B., Baty, F., Rochlitz, C., and Buess, M. (2012) Global gene expression analysis of the interaction between cancer cells and osteoblasts to predict bone metastasis in breast cancer. PLoS One 7, e29743
65. Han, W., Carpenter, R. L., Cao, X., and Lo, H. W. (2013) STAT1 gene expression is enhanced by nuclear EGFR and HER2 via cooperation with STAT3. Mol. Carcinog. 52, 959-969
66. Schultz, J., Koczan, D., Schmitz, U., Ibrahim, S. M., Pilch, D., Landsberg, J., and Kunz, M. (2010) Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth. Clin. Exp. Metastasis 27, 133-140
67. Fryknäs, M., Dhar, S., Oberg, F., Rickardson, L., Rydåker, M., Göransson, H., Gustafsson, M., Pettersson, U., Nygren, P., Larsson, R., and Isaksson, A. (2007) STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines. Int. J. Cancer 120, 189-195 (Pubitemid 44901935)
68. Khodarev, N. N., Beckett, M., Labay, E., Darga, T., Roizman, B., and Weichselbaum, R. R. (2004) STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc. Natl. Acad. Sci. U.S.A. 101, 1714-1719 (Pubitemid 38234220)
69. Khodarev, N. N., Roizman, B., and Weichselbaum, R. R. (2012) Molecular pathways: interferon/stat1 pathway: role in the tumor resistance to genotoxic stress and aggressive growth. Clin. Cancer Res. 18, 3015-3021
70. Patterson, S. G., Wei, S., Chen, X., Sallman, D. A., Gilvary, D. L., Zhong, B., Pow-Sang, J., Yeatman, T., and Djeu, J. Y. (2006) Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells. Oncogene 25, 6113-6122 (Pubitemid 44562409)
71. Rickardson, L., Fryknäs, M., Dhar, S., Lövborg, H., Gullbo, J., Rydåker, M., Nygren, P., Gustafsson, M. G., Larsson, R., and Isaksson, A. (2005) Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles. Br. J. Cancer 93, 483-492 (Pubitemid 43080025)
72. Rickardson, L., Fryknäs, M., Haglund, C., Lövborg, H., Nygren, P., Gustafsson, M. G., Isaksson, A., and Larsson, R. (2006) Screening of an annotated compound library for drug activity in a resistant myeloma cell line. Cancer Chemother. Pharmacol. 58, 749-758 (Pubitemid 44351254)
73. Franci, C., Zhou, J., Jiang, Z., Modrusan, Z., Good, Z., Jackson, E., and Kouros-Mehr, H. (2013) Biomarkers of residual disease, disseminated tumor cells, and metastases in theMMTV-PyMTbreast cancer model. PLoS One 8, e58183